Invion Limited (ASX:IVX)

1.7¢

right-arrow Created with Sketch. -0.001 (-5.56%)
MCAP $108.9M
Last trade 16.10pm 03/12/2021 20mins delayed

Latest Announcements

25/11/2021IVXInvion Limited
25/11/2021 Price SensitivePSIVXInvion Limited
24/11/2021IVXInvion Limited
23/11/2021IVXInvion Limited
23/11/2021IVXInvion Limited
23/11/2021IVXInvion Limited
23/11/2021IVXInvion Limited
23/11/2021 Price SensitivePSIVXInvion Limited
258
MCap

Company Overview

Invion Limited is an Australia-based life-sciences company. The Company is focused on the development of Photosoft technology for the treatment of a range of cancers. The Company is conducting various clinical trials for the development of its Photosoft technology. Its Photo Dynamic Therapy (PDT) is a treatment that optimizes the use of non-toxic photosensitizers and visible light to kill cancer and stimulate the immune system. The Company aims to develop photosensitizer, IVX-PDT, that improves the treatment of skin cancers and hard-to-treat solid cancers, such as those present in ovarian, prostate and lungs. Epitech Dermal Science Pty Ltd is the wholly owned subsidiary of the Company.

IVX in the news

Invion (IVX) is aiming to raise $15 million in additional capital to…
Invion (IVX) shares soar following its latest trial results, demonstrating a complete…
Life-science company Invion (IVX) has announced a new partnership, product, and $4.5…

Search Previous Announcements